Innate Pharma (IPHA)
Innate Pharma (IPHA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- IPHA last traded at $0.94 on 2026-11-19, -8.75% for the session.
- Innate Pharma: market cap $104.99M.
- Over the past year IPHA returned -47.78%, with a year-to-date return of -46.29%.